News
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
The Trump administration is considering a proposal to allow Medicare and Medicaid to cover expensive weight-loss drugs. GLP-1 ...
New weight-loss drugs are out of reach for millions of older Americans because Medicare won’t pay Debra Tyler’s daughter takes her new medication at home in Killingworth, Conn.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results